Sagent Pharmaceuticals Expands into Diagnostic Dye Market with Bludigo® Launch Sagent Pharmaceuticals has partnered with Provepharm to launch Bludigo®, an FDA-approved indigo carmine injection, marking its entry into the diagnostic dye sector.

Sagent Pharmaceuticals Expands into Diagnostic Dye Market with Bludigo® Launch #United_States #Schaumburg #Sagent_Pharmaceuticals #Bludigo #Provepharm

Sagent Pharmaceuticals Enters Ophthalmic Market with Launch of Travoprost Solution Sagent Pharmaceuticals has officially entered the ophthalmic sector by launching Travoprost, an innovative solution aimed at lowering eye pressure.

Sagent Pharmaceuticals Enters Ophthalmic Market with Launch of Travoprost Solution #United_States #Schaumburg,_Illinois #Sagent_Pharmaceuticals #Travoprost #Ophthalmic_Solution

Sagent Pharmaceuticals and Qilu Team Up to Enhance U.S. Access to Injectable Medicines Sagent Pharmaceuticals and Qilu Pharmaceutical join forces to improve U.S. access to critical injectable solutions, addressing significant healthcare needs.

Sagent Pharmaceuticals and Qilu Team Up to Enhance U.S. Access to Injectable Medicines #United_States #Schaumburg #Qilu_Pharmaceutical #Sagent_Pharmaceuticals #Injectable_Products